← Leaderboards
Cheng-Kui Qu
Emory University
$14,877,721
Attributed
$14,877,721
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,877,721 · 12
By mechanism
R01$12,300,845 · 5
R21$2,453,604 · 6
K18$123,272 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Jason M Grayson$2,987,608
- Sara Fielder$88,568
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHematopoieticHematopoietic Stem CellsStem CellsPlayLeukemiaMolecularMutantProtein Tyrosine PhosphatasePhosphoric Monoester HydrolasesBaseLaboratoriesProteinsMutationResponsePathogenesisHematologic NeoplasmsLeadSignal TransductionHematopoiesisBone MarrowMyeloproliferative DiseaseJuvenile Myelomonocytic LeukemiaKnock-In Mouse
Grant awards (47)
Metabolic regulation of stem cell niche development and function$488,138
R01 · FY2025 · HL · contact PI
Targeting leukemic stem cells in acute myeloid leukemia$422,159
R01 · FY2025 · CA · contact PI
Metabolic regulation of stem cell niche development and function$485,267
R01 · FY2024 · HL · contact PI
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment$440,263
R01 · FY2024 · HL · contact PI
Targeting leukemic stem cells in acute myeloid leukemia$401,054
R01 · FY2024 · CA · contact PI
Eradicating leukemic stem cells in juvenile myelomonocytic leukemia$208,517
R21 · FY2024 · CA · contact PI
Metabolic regulation of stem cell niche development and function$502,002
R01 · FY2023 · HL · contact PI
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment$456,199
R01 · FY2023 · HL · contact PI
Targeting leukemic stem cells in acute myeloid leukemia$422,157
R01 · FY2023 · CA · contact PI
Eradicating leukemic stem cells in juvenile myelomonocytic leukemia$182,909
R21 · FY2023 · CA · contact PI
Metabolic regulation of stem cell niche development and function$508,625
R01 · FY2022 · HL · contact PI
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment$462,947
R01 · FY2022 · HL · contact PI
Synthetic lethality in leukemic stem cells in juvenile myelomonocytic leukemia$214,414
R21 · FY2022 · CA · contact PI
Germline mutations of PTPN11 (SHP2) in the stem cell microenvironment$422,325
R01 · FY2021 · HL · contact PI
Synthetic lethality in leukemic stem cells in juvenile myelomonocytic leukemia$182,325
R21 · FY2021 · CA · contact PI
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment$390,000
R01 · FY2019 · HL · contact PI
Metabolic regulation of hematopoietic stem cells$273,000
R01 · FY2019 · DK · contact PI
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment$390,000
R01 · FY2018 · HL · contact PI
Metabolic regulation of hematopoietic stem cells$273,000
R01 · FY2018 · DK · contact PI
Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndrome$234,000
R21 · FY2018 · HD · contact PI
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment$390,000
R01 · FY2017 · HL · contact PI
Metabolic regulation of hematopoietic stem cells$273,000
R01 · FY2017 · DK · contact PI
Targeting SHP2 phosphatase for chemoprevention of leukemic progression in Noonan syndrome$195,000
R21 · FY2017 · HD · contact PI
Germline mutations of PTPN11 (SHP-2) in the stem cell microenvironment$390,000
R01 · FY2016 · HL · contact PI
Metabolic regulation of hematopoietic stem cells$273,000
R01 · FY2016 · DK · contact PI
Targeting metabolism in leukemic stem cells$203,580
R21 · FY2015 · CA · contact PI
Metabolic regulation of hematopoietic stem cell function$338,520
R01 · FY2014 · DK · contact PI
Targeting metabolism in leukemic stem cells$169,650
R21 · FY2014 · CA · contact PI
Metabolic regulation of hematopoietic stem cell function$328,766
R01 · FY2013 · DK · contact PI
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation$382,388
R01 · FY2012 · HL · contact PI
Metabolic regulation of hematopoietic stem cell function$340,690
R01 · FY2012 · DK · contact PI
Targeting SHP2 Phosphatase for Hematologic Malignancies in Noonan Syndrome$235,500
R21 · FY2012 · HD · contact PI
Metabolic regulation of hematopoietic stem cell function$12,560
R01 · FY2012 · DK · contact PI
Metabolic regulation of hematopoietic stem cell function$392,500
R01 · FY2011 · DK · contact PI
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation$386,250
R01 · FY2011 · HL · contact PI
Targeting SHP2 Phosphatase for Hematologic Malignancies in Noonan Syndrome$196,250
R21 · FY2011 · HD · contact PI
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation$386,250
R01 · FY2010 · HL · contact PI
PTPMT1 Phosphatase and Hematopoietic Stem Cell Function$123,272
K18 · FY2010 · HL · contact PI
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation$386,250
R01 · FY2009 · HL · contact PI
Protein Tyrosine Phosphatase and Hematopoietic Cell Regulation$386,250
R01 · FY2008 · HL · contact PI
SHP-2 Inhibitors as Potential Therapeutic Agents for JMML and Noonan Syndrome$228,162
R21 · FY2008 · HL · contact PI
SHP-2 Inhibitors as Potential Therapeutic Agents for JMML and Noonan Syndrome$203,297
R21 · FY2007 · HL · contact PI
Tyrosine Phosphatases and Hematopoietic Cell Regulation$169,950
R01 · FY2007 · HL · contact PI
Tyrosine Phosphatases and Hematopoietic Cell Regulation$347,625
R01 · FY2005 · HL
Tyrosine Phosphatases and Hematopoietic Cell Regulation$162,910
R01 · FY2004 · HL
Tyrosine Phosphatases and Hematopoietic Cell Regulation$308,400
R01 · FY2003 · HL
Tyrosine Phosphatases and Hematopoietic Cell Regulation$308,400
R01 · FY2002 · HL